National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Insurance Coverage: Maryland
    Posted: 12/19/2002    Reviewed: 12/17/2008
Page Options
Print This Page
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Maintenance Rituximab for Follicular Lymphoma

Azacitidine Improves Survival in MDS

Second Stem Cell Transplant Not Helpful in Myeloma

For more information about insurance coverage of clinical trial costs, see this feature's main page: States That Require Health Plans to Cover Patient Care Costs in Clinical Trials.


Legislation: Senate Bill 137, House Bill 45

Effective: July 1998

What clinical trials are covered?

Phase I, II, III, and IV cancer treatment, supportive care, early detection, and prevention trials. Phase II, III, and IV trials for other life-threatening conditions, with Phase I trials considered on a case-by-case basis.

Trial must be conducted by an academic medical center in Maryland or approved by one of the following:

  • National Institutes of Health (NIH)
  • an NIH-sponsored cooperative group or center
  • U.S. Department of Veterans Affairs
  • U.S. Food and Drug Administration

Who is required to pay?

Private insurers and other specified managed care plans.

Other key provisions:

  • There is no clearly superior, noninvestigational alternative.
  • The data provide a reasonable expectation that the treatment will be as least as effective as the alternative.

Back to Top


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov